Corticosteroids

32149773 ä. Effectiveness of glucocorticoid therapy in patients with severe coronavirus disease 2019: protocol of a randomized controlled trial
32272008 2020. Early preemptive immunomodulators (corticosteroids) for severe pneumonia patients infected with SARS-CoV-2
32341100 2020. Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective
32321620 ä. Corticosteroid use for 2019-nCoV infection: A double-edged sword
32283153 ä. Low-dose corticosteroid therapy does not delay viral clearance in patients with COVID-1
32389783 2020. Re: Low-dose corticosteroid therapy does not delay viral clearance in patients with COVID-19.
32122468 2020. On the use of corticosteroids for 2019-nCoV pneumonia
32043983 2020. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury
32372026 ä. Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis
32341331 2020. A retrospective cohort study of methylprednisolone therapy in severe patients with COVID-19 pneumonia
32133159 2020. Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia
32266987 2020. Corticosteroid treatment of patients with coronavirus disease 2019 (COVID-19)
32164084 2020. Expert consensus on the use of corticosteroid in patients with 2019-nCoV pneumonia
32296012 2020. Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia
C7189003 2020. Glukokortikoide und Covid-19
32475851 2020. COVID-19: Stay Cool toward Corticosteroids.
32409522 2020. Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis.
32427279 2020. Early Short Course Corticosteroids in Hospitalized Patients with COVID-19.
32474331 2020. Corticosteroids and the hyper-inflammatory phase of the COVID-19 disease.
32514902 2020. Systemic steroids in patients with COVID-19: pros and contras, an endocrinological point of view.
32283144 2020. The effect of corticosteroid treatment on patients with coronavirus infection: a systematic review and meta-analysis.
32391369 2020. Use of Corticosteroids in Coronavirus Disease 2019 Pneumonia: A Systematic Review of the Literature.
32417314 2020. Corticosteroid use in selected patients with severe acute respiratory distress syndrome related to COVID-19.
32437628 2020. COVID-19, Asthma, and Inhaled Corticosteroids (ICS): Another Beneficial Effect of ICS?
32470160 2020. Glucocorticoid therapy delays the clearance of SARS-CoV-2 RNA in an asymptomatic COVID-19 patient.
32441786 2020. Effects of methylprednisolone use on viral genomic nucleic acid negative conversion and CT imaging lesion absorption in COVID-19 patients under 50 years old.
32034899 2020. [Expert consensus on the use of corticosteroid in patients with 2019-nCoV pneumonia].
32479759 2020. Successful use of methylprednisolone for treating severe COVID-19.
32496422 2020. Effects of Corticosteroid Treatment for Non-Severe COVID-19 Pneumonia: A Propensity Score-Based Analysis.
32464115 2020. Caution against corticosteroid-based COVID-19 treatment.
32519174 2020. What can we learn about corticosteroid therapy as a treatment for COVID-19?
32532461 2020. Eficacia de los pulsos de corticoides en pacientes con sindrome de liberacion de citocinas inducido por infeccion por SARS-CoV-2.
32514354 2020. High-dose, short-term corticosteroids for ARDS caused by COVID-19: a case series.
32491104 2020. Clinical characteristics and therapeutic procedure for a critical case of novel coronavirus pneumonia treated with glucocorticoids and non-invasive ventilator treatment.
32571831 2020. IMPACT OF GLUCOCORTICOID TREATMENT IN SARS-COV-2 INFECTION MORTALITY: A RETROSPECTIVE CONTROLLED COHORT STUDY.
32548723 2020. Impact of anti-rheumatic drugs and steroids on clinical course and prognosis of COVID-19.
32585180 2020. Use of inhaled corticosteroids in asthma and COVID-19 : Keep calm and carry on.
32588377 2020. Corticosteroids in diabetes patients infected with COVID-19.
32570995 2020. Short-Term Dexamethasone in Sars-CoV-2 Patients.
32576548 2020. Covid-19: Demand for dexamethasone surges as RECOVERY trial publishes preprint.
32546467 2020. Covid-19: Low dose steroid cuts death in ventilated patients by one third, trial finds.
32590699 2020. ACTH 1-24 and other melanocortins for COVID-19 treatment.
32566564 2020. Effectiveness and safety of glucocorticoids to treat COVID-19: a rapid review and meta-analysis.
32548616 2020. Corticosteroids in patients with COVID-19: what about the control group?
32451729 2020. Corticosteroid treatment in severe COVID-19 pneumonia: two cases and literature review.
32588877 2020. High-dose but not low-dose corticosteroids potentially delay viral shedding of patients with COVID-19.
32585016 2020. THE RIGHT TIME FOR STEROIDS IN COVID-19.
32603802 2020. Corticosteroid administration for viral pneumonia: COVID-19 and beyond.
32430057 2020. Adjuvant corticosteroid therapy for critically ill patients with COVID-19.
32610262 2020. Role of corticosteroid in the management of COVID-19: A systemic review and a Clinician's perspective.
32394335 2020. Corticosteroids for critically ill COVID-19 patients with cytokine release syndrome: a limited case series.
32551464 2020. Dexamethasone for COVID-19? Not so fast.
32603493 2020. Methylprednisolone added to tocilizumab reduces mortality in SARS-CoV-2 pneumonia: An observational study.
32482571 2020. Consensus statement. Corticosteroid therapy in ENT in the context of the COVID-19 pandemic.

32546811 2020. Coronavirus breakthrough: dexamethasone is first drug shown to save lives.

32538585 2020. Reply to: What we are talking about when we talk of steroid in COVID-19?
32530507 2020. Can steroids reverse the severe COVID-19 induced "cytokine storm"?
32383835 2020. Acute respiratory distress syndrome and steroids in the shadow of coronavirus disease 2019.